1. Medtech Insight
  2. >>Business
  3. >>R&D
  4. >>Clinical Trials

Starts & Stops: Small Players Advance Innovations, Three Trials Suspended

 
• By Tina Tan

Starts & Stops is a regular feature highlighting the Medtech Insight editors' picks of noteworthy medtech clinical trial initiations, completions and suspensions from the previous month. July's selection includes three trials that had to be terminated unexpectedly.

Clinical Trial

Several smaller, venture-backed medtech players initiated new clinical trials in July, as recorded by Informa's Meddevicetracker. Among the notable studies started last month are Bigfoot Biomedical Inc.'s US study of the Bigfoot smartloop artificial pancreas system for type 1 diabetes patients; ALung Technologies Inc.'s phase III study of its Hemolung RAS, a respiratory dialysis system that is also enrolled in the US FDA's Expedited Access Pathway; and Mercator MedSystems Inc.'s phase II pilot trial of its Bullfrog microinfusion device for treating critical limb ischemia. (Also see "Mercator Launches Trial Of Micro-Infusion Device For Lower-Leg Obstruction" - Medtech Insight, 28 July, 2016.)

There were also three companies that suspended their trials last month, all for different reasons. Sweden's XVIVO Perfusion AB, a...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

FDA Regulations ‘Lock Out’ Clinically Proven Neuromodulation Devices

 
• By Natasha Barrow

Flow Neuroscience's neuromodulation headset for the treatment of depression is approved and marketed in the EU. However, two years on, the company is still waiting for US FDA approval despite being assigned breakthrough device designation.

EU Pilot Features ‘All-In-One’ Regulatory Path For Drug/Diagnostic Trials

 
• By Vibha Sharma

The EU is testing a groundbreaking “all-in-one” process for reviewing combined drug and diagnostic trials via a single application for coordinated assessment.

Ceryx Medical Amasses £11M To Develop Adaptive Cardiac Pacing Technology

 
• By Natasha Barrow

The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.

SS Innovations’ SSI Mantra 3 Poised To Challenge Da Vinci In Robotic Surgery Market

 
• By Marion Webb

SS Innovations reported its first SSi Mantra 3 robotic cardiac surgery in South America as it prepares to file for US FDA de novo clearance and a CE mark. The firm aims to challenge Intuitive Surgical with a lower-cost, flexible system targeting US and European markets.

More from R&D

GE HealthCare Launches Intraoperative Ultrasound Product Series: bkActiv S

 
• By Natasha Barrow

GE HealthCare launches bkActiv S series – part of the bkPortfolio family of Active Imaging systems.

EU Pilot Features ‘All-In-One’ Regulatory Path For Drug/Diagnostic Trials

 
• By Vibha Sharma

The EU is testing a groundbreaking “all-in-one” process for reviewing combined drug and diagnostic trials via a single application for coordinated assessment.

Ceryx Medical Amasses £11M To Develop Adaptive Cardiac Pacing Technology

 
• By Natasha Barrow

The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.